David Einhorn Interview: David Einhorn Bloomberg Video Discussing Apple

Page 1 of 2

David Einhorn Interview: David Einhorn GREENLIGHT CAPITALDavid Einhorn, president at Greenlight Capital, has had a lot of interesting things to say about Apple Inc. (NASDAQ:AAPL) in the past. While you may not always agree with what Einhorn has to say, his advice is at least worth hearing out.

So, what is Einhorn saying about Apple Inc. (NASDAQ:AAPL) right now? Let’s get started by taking a quick peak at an article we published earlier today:

Billionaire Einhorn Urges Apple Inc. Shareholders To Oppose Company’s Proposal

Here is a brief excerpt to chew on:

“Greenlight Capital, Inc. (“Greenlight”), a value oriented, research-driven investment management firm, today announced that it is urging fellow shareholders of Apple Inc. (AAPL) (“Apple” or the “Company”) to oppose the Company’s attempt to amend its corporate charter.  Greenlight is voting AGAINST Proposal 2 in Apple’s proxy, which would eliminate preferred stock from Apple’s charter and thus restrict the Board’s ability to unlock the value on Apple’s balance sheet.  Greenlight is asking all shareholders to also vote AGAINST Proposal 2 at the upcoming Annual Meeting of Shareholders to be held on February 27, 2013.”

It does not matter if you agree or disagree with Einhorn, you should take a close look at what he has to say:

“We believe Apple must examine all of its options to unlock the growing value of its balance sheet for all shareholders. Over the past several months, we have had an ongoing dialogue with Apple regarding one option to do so, namely the creation of a new security, a perpetual preferred stock that would be distributed at no cost to Apple’s existing shareholders, and would provide an attractive, sustainable dividend while preserving Apple’s financial resources to pursue its business strategy.”

With all this in mind, it is time to move onto a recap of an interview with Einhorn on Bloomberg TV. In short, he discusses the “attractiveness to shareholders of Apple stock if the company pledged its entire cash holdings to a dividend.”

Here is the question from the interviewer that gets the interview started:

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!